醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
VCYT · VERACYTE, INC.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
VERACYTE, INC.（VCYT）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $1.4M；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-20。
買入 Bought—
賣出 Sold$1.4M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-19 | Bhanji Muna Director | 賣出 Sell | 1,864 | $43.70 | $81K | SEC |
| 2026-09-21 | Leite John Global Chief Commercial Off | 賣出 Sell | 4,015 | $40.00 | $161K | SEC |
| 2026-09-14 | Holstein Jens Director | 賣出 Sell | 5,000 | $40.95 | $205K | SEC |
| 2026-09-04 | Chambers Rebecca Chief Financial Officer | 賣出 Sell | 3,652 | $43.10 | $157K | SEC |
| 2026-09-04 | Febbo Phillip G. Chief Scientific & Med Officer | 賣出 Sell | 13,110 | $43.05 | $564K | SEC |
| 2026-09-04 | McGuire Annie EVP, General Counsel | 賣出 Sell | 3,254 | $43.09 | $140K | SEC |
| 2026-09-01 | Bhanji Muna Director | 賣出 Sell | 1,864 | $42.97 | $80K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-09-24 | Holstein Jens Director | 7,500 | $352K | 10b5-1 |
| 2026-09-21 | Leite John Officer | 4,015 | $160K | 10b5-1 |
| 2026-09-14 | Holstein Jens Director | 5,000 | $205K | 10b5-1 |
| 2026-09-04 | Febbo Phillip G. Officer | 13,110 | $586K | 10b5-1 |
| 2026-09-04 | Chambers Rebecca Officer | 3,652 | $163K | 10b5-1 |
| 2026-09-04 | McGuire Annie Officer | 3,254 | $145K | 10b5-1 |
| 2026-09-01 | Bhanji Muna Director | 3,728 | $161K | 10b5-1 |
內部人 Insiders
Bhanji Muna、Leite John、Holstein Jens、Chambers Rebecca、Febbo Phillip G.、McGuire Annie